Averitas Drug Patent Portfolio

Averitas owns 1 orange book drug protected by 8 US patents Given below is the list of Averitas's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8821920 Therapeutic patch for transdermal delivery of capsaicin 26 Mar, 2030
Active
US9226903 Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer 15 Dec, 2028
Active
US10034841 Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer 06 Sep, 2025
Active
US10463598 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023 Expired
US10869827 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023 Expired
US8263059 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023 Expired
US8889113 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023 Expired
US6239180 Transdermal therapeutic device and method with capsaicin and capsaicin analogs 06 Nov, 2016 Expired


Given below is the list of recent legal activities going on the following drug patents of Averitas.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 29 Apr, 2024 US8263059
Payment of Maintenance Fee, 8th Year, Large Entity 28 Jun, 2023 US9226903
Payment of Maintenance Fee, 4th Year, Large Entity 19 Apr, 2023 US10463598
Payment of Maintenance Fee, 8th Year, Large Entity 04 May, 2022 US8889113
Payment of Maintenance Fee, 8th Year, Large Entity 24 Feb, 2022 US8821920
Payment of Maintenance Fee, 4th Year, Large Entity 25 Jan, 2022 US10034841
Patent Issue Date Used in PTA Calculation 22 Dec, 2020 US10869827
Recordation of Patent Grant Mailed 22 Dec, 2020 US10869827
Email Notification 03 Dec, 2020 US10869827
Issue Notification Mailed 02 Dec, 2020 US10869827
Dispatch to FDC 23 Nov, 2020 US10869827
Application Is Considered Ready for Issue 17 Nov, 2020 US10869827
Issue Fee Payment Received 13 Nov, 2020 US10869827
Issue Fee Payment Verified 13 Nov, 2020 US10869827
Electronic Review 18 Sep, 2020 US10869827


Averitas's Family Patents

Averitas drugs have patent protection in a total of 29 countries. It's US patent count contributes only to 21.1% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Averitas Drug List

Given below is the complete list of Averitas's drugs and the patents protecting them.


1. Qutenza

Qutenza is protected by 8 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8821920 Therapeutic patch for transdermal delivery of capsaicin 26 Mar, 2030
(5 years from now)
Active
US9226903 Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer 15 Dec, 2028
(4 years from now)
Active
US10034841 Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer 06 Sep, 2025
(10 months from now)
Active
US10463598 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023
(1 year, 1 month ago)
Expired
US10869827 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023
(1 year, 1 month ago)
Expired
US8263059 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023
(1 year, 1 month ago)
Expired
US8889113 Compositions and kits for the removal of irritating compounds from bodily surfaces 05 Sep, 2023
(1 year, 1 month ago)
Expired
US6239180 Transdermal therapeutic device and method with capsaicin and capsaicin analogs 06 Nov, 2016
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qutenza's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List